Results for tag: "Intermittent Explosive Disorder"

Intermittent Explosive Disorder (IED) is a mental health disorder characterized by sudden outbursts of aggressive, violent, or angry behavior. It is estimated to affect up to 16 million people in the United States alone. Symptoms of IED include verbal and physical aggression, destruction of property, and threats of violence. People with IED often experience feelings of guilt, shame, and regret after an outburst. Treatment for IED typically includes psychotherapy, medication, and lifestyle changes. Cognitive Behavioral Therapy (CBT) is often used to help people with IED identify and manage triggers for their outbursts. Medications such as antidepressants and mood stabilizers may also be prescribed to help manage symptoms. Companies in the Intermittent Explosive Disorder market include Neurocrine Biosciences, Inc., Otsuka Pharmaceutical Co., Ltd., and Lundbeck A/S. Show Less Read more